Cue Biopharma (CUE) Other Operating Expenses (2022 - 2025)
Cue Biopharma (CUE) posted Other Operating Expenses of $20000.0 for Q4 2025, up 139.22% sequentially from -$51000.0 in Q3 2025, and up 600.0% YoY from $2857.1 in Q4 2024.
Cue Biopharma (CUE) Other Operating Expenses (2022 - 2025) Analysis & Trends
Cue Biopharma has reported Other Operating Expenses for 4 years, with the latest figure at $20000.0 in Q4 2025.
- Quarterly Other Operating Expenses rose 600.0% year-over-year to $20000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$31000.0 (down 133.33% YoY) and the FY2025 annual result came in at -$31000.0, down 133.33% from the prior year.
- Other Operating Expenses advanced to $20000.0 in Q4 2025 per CUE's latest filing, from -$51000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $97000.0 in Q3 2024 and troughed at -$258000.0 in Q2 2022.
- A 4-year average of -$53142.9 and a median of -$19000.0 in 2022 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2023 and 2025: Other Operating Expenses plunged 726.32% in 2023, then jumped 600.0% in 2025.
- Over 4 years, Other Operating Expenses stood at -$19000.0 in 2022, then slumped by 726.32% to -$157000.0 in 2023, then jumped by 97.45% to -$4000.0 in 2024, then surged by 600.0% to $20000.0 in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $20000.0, -$51000.0, and -$4000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | -51,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | 97,000.00 |
| Dec 31, 2023 | -157,000.00 |
| Dec 31, 2022 | -19,000.00 |
| Jun 30, 2022 | -258,000.00 |